Alzheimer's Amyloid Drug Fails to Slow Cognitive Decline in Clinical Trial

Alzheimer's Amyloid Drug Fails to Slow Cognitive Decline in Clinical Trial  Genetic Engineering & Biotechnology News Alzheimer's drug targeting soluble amyloid falls short in a large clinical trial  Medical Xpress Trial of solanezumab for mild dementia due to Alzheimer disease  Pharmacy Today, American Pharmacists Association, pharmacist.com Energy storehouses in the brain may be source of Alzheimer's, targets of new therapy  Science DailyFull coverage

Read More ...
Alzheimer's Amyloid Drug Fails to Slow Cognitive Decline in Clinical Trial published January 25, 2018 at 09:43PM. Original Source Link : https://www.genengnews.com/gen-news-highlights/alzheimers-amyloid-drug-fails-to-slow-cognitive-decline-in-clinical-trial/81255420

loading...